HIV infections Trials in Las Vegas, United States
Conditions / HIV infections / Las Vegas, United States
HIV infections has been the subject of sustained clinical investigation across multiple research sites.
37 total trials for this combination
Showing top 10 of 37 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00146328 | Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects | COMPLETED | PHASE2/PHASE3 |
| NCT00054717 | Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST) | COMPLETED | PHASE3 |
| NCT05911360 | A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00062660 | Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection | APPROVED_FOR_MARKETING | — |
| NCT00002441 | Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection | COMPLETED | PHASE3 |
| NCT00245739 | TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens. | APPROVED_FOR_MARKETING | — |
| NCT03446573 | Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO) | COMPLETED | PHASE3 |
| NCT00097799 | Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection | APPROVED_FOR_MARKETING | — |
| NCT00046345 | Atazanavir for HIV Infected Individuals: An Early Access Program | NO_LONGER_AVAILABLE | — |
| NCT00002378 | A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients | COMPLETED | PHASE3 |